- Sales of Torrent’s copycat are blocked until the 10 patents have expired “except as otherwise provided in the settlement agreement” and “unless pursuant to a license,” according to
consent judgment approved Thursday in federal court in Wilmington, Delaware - Latest of patents’ expirations is August 2032: FDA Orange Book
- Patents held by Bial and licensed exclusively to Sunovion
- Aptiom, trailing only Latuda among Sumitomo’s biggest drugs, had North American sales of $124 million in the first half of ...
CORRECT: Sumitomo, Torrent Settle Patent Suit on Aptiom Drug
Nov. 19, 2021, 4:35 PM